News

Researchers have found in two longitudinal cohorts that Incorporating chest CT imaging and respiratory symptoms into the ...
There are a wide range of behaviors and symptoms in patients with eating disorders that are not captured by current diagnostic criteria, new research suggests.
Comparable clinical outcomes were found between individuals with airflow obstruction who no longer had COPD per new diagnostic schema and individuals without COPD, according to the study.
New findings from the MATINEE and COPD-HELP studies suggest mepolizumab could reduce exacerbations and improve quality of life in patients with eosinophilic chronic obstructive pulmonary disease ...
About The Study: A new chronic obstructive pulmonary disease (COPD) diagnostic schema integrating respiratory symptoms, respiratory quality of life, spirometry, and structural lung ...
Mepolizumab is a humanized monoclonal antibody that targets interleukin-5, a cytokine that plays a central role in eosinophilic inflammation, which is present in 20 to 40% of patients with chronic ...
Gabapentinoid use in patients with chronic obstructive pulmonary disease (COPD) was associated with a higher risk for severe exacerbations, a population-based cohort study from Canada indicated ...
Researchers found that the risk for moderate or severe COPD exacerbation was lower among those treated with SGLT-2is vs DPP-4is and among those treated with GLP-1 RAs vs DPP-4is.
Research reveals GLP-1 and SGLT-2 medications may lower COPD exacerbation risk in diabetes, offering new hope for dual condition management.
People with type 2 diabetes who take GLP-1 and SGLT-2 medications have a lower risk of having COPD symptom flare-ups than those other diabetes drugs.
The study reveals SGLT-2is are linked to fewer COPD exacerbations in type 2 diabetes, suggesting a need for further clinical trials to confirm these findings.
A COPD exacerbation can feel scary in the moment, and it’s natural to experience lingering worry about another flare-up. Having a set of go-to tips can help you mentally cope during — and ...